Ignite Creation Date:
2024-05-05 @ 5:30 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00460083
Status:
COMPLETED
Last Update Posted:
2008-02-06
First Post:
2007-04-11
Brief Title:
Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis
Sponsor:
Ceragenix Pharmaceuticals
Organization:
Ceragenix Pharmaceuticals
Organization Data
Organization:
Ceragenix Pharmaceuticals
Class:
INDUSTRY
Study ID:
CGXP - 060674 IRB00002569
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ceragenix Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Sr Vice President Research Development
Old Organization:
Ceragenix Pharmaceuticals Inc